DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216443 Jan 26, 2024 - Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer. 0

https://www.zacks.com/stock/news/2224681/labcorp-lh-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224681 Feb 12, 2024 - Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2227695/compared-to-estimates-labcorp-lh-q4-earnings-a-look-at-key-metrics-revised?cid=CS-ZC-FT-fundamental_analysis|nfm-2227695 Feb 19, 2024 - Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.zacks.com/stock/news/2239239/are-investors-undervaluing-labcorp-lh-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2239239 Mar 12, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2242254/labcorp-lh-presents-new-research-on-precision-diagnostics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242254 Mar 18, 2024 - Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer. 0

https://www.zacks.com/stock/news/2248657/labcorp-lh-to-boost-clinical-diagnostics-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2248657 Apr 01, 2024 - The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services. 0

https://www.zacks.com/stock/news/2219761/labcorp-lh-unveils-test-for-preeclampsia-in-pregnant-women?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2219761 Feb 01, 2024 - Labcorp (LH) test System, which is available through clinicians, is the first FDA-cleared biomarker test to aid in the risk assessment of progression to severe preeclampsia. 0

https://www.zacks.com/stock/news/2223452/analysts-estimate-labcorp-lh-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223452 Feb 08, 2024 - Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2249325/here-s-why-investors-should-retain-labcorp-lh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249325 Apr 02, 2024 - Investors are optimistic about Labcorp (LH) on the continued strength of Central Labs, which is driving the success of the biopharma segment. 0

https://www.zacks.com/stock/news/2252021/labcorp-lh-extends-mrd-clinical-research-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2252021 Apr 08, 2024 - Labcorp (LH) Plasma Detect MRD solution advances its leadership in precision oncology across the solid tumor oncology care continuum. 0